AnalystBook Research · Company Intelligence

OS Therapies Inc

OSTXNYSE

Built from OS Therapies Inc's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -71.64 distress zone — historically elevated failure riskWatch

Leadership changes

From OS Therapies Inc's own filings, the day they're filed.

  • Karim Galzahr · directors · departureeff. 2026-06-01
  • Craig Eagle · directors · departureeff. 2026-06-01
  • Karim Galzahr · directors · appointmenteff. 2025-01-28

Latest filings

  • 8-K · Company announcement2026-08-21
  • 10-Q · Quarterly report2026-08-14
  • 8-K · Company announcement2026-08-12
  • 8-K · Company announcement2026-08-06
  • 8-K · Company announcement2026-07-29
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about OS Therapies Inc, every answer cited to the official filings🔒
  • The Intelligence Brief — added when OS Therapies Inc's brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.